Pfizer Inc., the drugmaker that yesterday said it would acquire rival Wyeth for $68 billion, took a $2.3 billion charge for a record settlement of U.S. investigations into improper marketing of its Bextra painkiller and other drugs.
Yahoo! Buzz: Top Stories, Yahoo Buzz
Tue, 01/27/2009 - 1:30am
Pfizer Inc., the drugmaker that yesterday said it would acquire rival Wyeth for $68 billion, took a $2.3 billion charge for a record settlement of U.S. investigations into improper marketing of its Bextra painkiller and other drugs.